References
- Yun BY, Jun SY, Kim NA, et al. Crystal structure and thermostability of a putative alpha-glucosidase from Thermotoga neapolitana. Biochem Biophys Res Commun 2011;416:92–8
- Dill KA. Dominant forces in protein folding. Biochemistry 1990;29:7133–55
- Jeong SH. Analytical methods and formulation factors to enhance protein stability in solution. Arch Pharm Res 2012;3:1871–86
- Gu LC, Erdos EA, Chiang HS, et al. Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implications. Pharm Res 1991;8:485–90
- Nielsen L, Khurana R, Coats A, et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 2001;40:6036–46
- Krishnan S, Chi EY, Webb JN, et al. Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. Biochemistry 2002;41:6422–31
- Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962;237:1555–62
- Starkey RH, Cohen S, Orth DN. Epidermal growth factor: identification of a new hormone in human urine. Science 1975;189:800–2
- Yip TT, Tsao SW, Ko KM, et al. Shrew submaxillary gland epidermal growth factor: homologous radioreceptor assay and mitogenic activity. Mol Cell Endocrinol 1986;47:131–5
- Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193–216
- Chvapil M, Gaines JA, Gilman T. Lanolin and epidermal growth factor in healing of partial-thickness pig wounds. J Burn Care Rehabil 1988;9:279–84
- DiBiase MD, Rhodes CT. Investigations of epidermal growth factor in semisolid formulations. Pharm Acta Helv 1991;66:165–9
- Sheardown H, Clark H, Wedge C, et al. A semi-solid drug delivery system for epidermal growth factor in corneal epithelial wound healing. Curr Eye Res 1997;16:183–90
- Taylor JM, Mitchell WM, Cohen S. Epidermal growth factor. Physical and chemical properties. J Biol Chem 1972;247:5928–34
- Son K, Kwon C. Stabilization of human epidermal growth factor (hEGF) in aqueous formulation. Pharm Res 1995;12:451–4
- Lee KW, Hwang KH, Kim CS, et al. Determination of recombinant human epidermal growth factor (rhEGF) in a pharmaceutical formulation by high performance liquid chromatography with electrochemical detection. Arch Pharm Res 2001;24:355–9
- Yang CH, Wu PC, Huang YB, Tsai YH. A new approach for determining the stability of recombinant human epidermal growth factor by thermal Fourier transform infrared (FTIR) microspectroscopy. J Biomol Struct Dyn 2004;22:101–10
- Kim NA, An IB, Lee SY, et al. Optimization of protein solution by a novel experimental design method using thermodynamic properties. Arch Pharm Res 2012;35:1609–19
- Sauerborn M, Brinks V, Jiskoot W, Schellekens H. Immunological mechanism underlying the immune response to recombinant human protein therapeutics. Trends Pharmacol Sci 2010;31:53–9
- Michnik A, Drzazga Z, Kluczewska A, Michalik K. Differential scanning microcalorimetry study of the thermal denaturation of haemoglobin. Biophys Chem 2005;118:93–101
- Bouchard M, Zurdo J, Nettleton EJ, et al. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci 2000;9:1960–7
- Sakudo A, Kuratsune H, Kato YH, Ikuta K. Secondary structural changes of proteins in fingernails of chronic fatigue syndrome patients from Fourier-transform infrared spectra. Clin Chim Acta 2009;402:75–8
- Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001;47:3–19
- Krimm S, Bandekar J. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv Protein Chem 1986;38:181–364
- Dong A, Prestrelski SJ, Allison SD, Carpenter JF. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. J Pharm Sci 1995;84:415–24
- Santana H, Gonzalez Y, Campana PT, et al. Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients. Int J Pharm 2013;452:52–62
- Patil S, Sandberg A, Heckert E, et al. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 2007;28:4600–7
- Tian F, Middaugh CR, Offerdahl T, et al. Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. Int J Pharm 2007;335:20–31
- Zhang Z, Boyle PC, Lu BY, et al. Entropic folding pathway of human epidermal growth factor explored by disulfide scrambling and amplified collective motion simulations. Biochemistry 2006;45:15269–78
- Sanchez-Ruiz JM. Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. Biophys J 1992;61:921–35
- Yang C-H, Huang Y-B, Wu P-C, Tsai Y-H. The evaluation of stability of recombinant human epidermal growth factor in burn-injured pigs. Process Biochem 2005;40:1661–5